For many patients, the challenge is not just the number on the scale it is the cycle of fatigue, reduced activity, fluid retention, and discouragement that can make healthy habits feel less effective, which is why treating thyroid disease well and considering additional weight-loss support when appropriate can both matter
The most effective approach for each patient depends on factors such as metabolic health, lifestyle, treatment tolerance, and personal goals
adults took GLP-1 medications for weight loss purposes in 2026, according to the Gallup National Health and Well-Being Index
GLP-1 medications can produce relatively rapid weight loss, which tends to increase the likelihood of excess skin compared to gradual loss through diet and exercise alone
Helps support structured program documentation and care planning
23 The FDA recommends that patients remain on each dose of certain GLP-1 RA therapies, namely semaglutide, dulaglutide, and tirzepatide, for at least 4 weeks before dose increases